SCHEMBL13613596

SCHEMBL13613596

CCOC(=O)c1ccc(NC(=O)Nc2cccc3c2CC(O)CC3)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 10/20 0.55
MAPT P10636 6/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CASP3 P42574 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
RAB9A P51151 2/20 0.49
TDP1 Q9NUW8 1/20 0.47
ABL1 P00519 1/20 0.47
HTT P42858 1/20 0.47
RIN1 Q13671 1/20 0.47
POLB P06746 1/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339136 0.90 TRPV1 (0.55) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL2734522 0.90 TRPV1 (0.51) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL2734043 0.87 TRPV1 (0.52) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL13613652 0.86 TRPV1 (0.53) TRPV1MAPTTP53SMN1; SMN2
SCHEMBL13613593 0.85 TRPV1 (0.52) TRPV1KMT2ATDP1SMN1; SMN2TSHR
SCHEMBL13613705 0.85 TRPV1 (0.56) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL13613697 0.85 TRPV1 (0.62) TRPV1RAB9APOLBNPC1
SCHEMBL13613591 0.82 TRPV1 (0.59) TRPV1MAPTMEN1KMT2ARAB9A
SCHEMBL24192057 0.81 TRPV1 (0.50) TRPV1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL13613710 0.81 TRPV1 (0.64) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed